Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) EBITDA Margin: 2016-2025

Historic EBITDA Margin for cbdMD (YCBD) over the last 10 years, with Sep 2025 value amounting to -11.27%.

  • cbdMD's EBITDA Margin fell 758.00% to -14.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.27%, marking a year-over-year increase of 537.00%. This contributed to the annual value of -11.27% for FY2025, which is 537.00% up from last year.
  • According to the latest figures from FY2025, cbdMD's EBITDA Margin is -11.27%, which was up 32.28% from -16.64% recorded in FY2024.
  • cbdMD's EBITDA Margin's 5-year high stood at -11.27% during FY2025, with a 5-year trough of -210.83% in FY2022.
  • Over the past 3 years, cbdMD's median EBITDA Margin value was -16.64% (recorded in 2024), while the average stood at -39.22%.
  • As far as peak fluctuations go, cbdMD's EBITDA Margin crashed by 16,939bps in 2022, and later soared by 12,108bps in 2023.
  • Over the past 5 years, cbdMD's EBITDA Margin (Yearly) stood at -41.44% in 2021, then tumbled by 16,939bps to -210.83% in 2022, then spiked by 12,108bps to -89.76% in 2023, then skyrocketed by 7,312bps to -16.64% in 2024, then surged by 537bps to -11.27% in 2025.